Reversing non-formulary status will usually require new data. The message developed in this article is that for products not on a hospital’s formulary, getting on formulary goes beyond what might be ...

Successful formulary system management can help ACOs achieve high quality, low cost objectives across the care continuum. This article targets healthcare leaders choosing to participate in the ...

Pharmacy benefit manager Express Scripts announced Dec. 12 the creation of a formulary to increase provider trust in and patient access to digital and mobile health apps and devices, including those ...

Healthcare lease accounting insights: How two organizations got compliant and stay audit-ready all year long Healthcare organizations (HCOs) often hold multiple leases such as those for real estate, ...

The hospital formulary system is an ongoing process that evaluates and selects the safest, most effective, and most economical care for hospitalized patients. As healthcare continues to change, so ...

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Acacia Pharma Group plc Barhemsys® and Byfavo® launches continue to show ...

Sheldon S. Sones, RPh, FASCP, is president of Sheldon S. Sones and Associates, a pharmacy and accreditation consulting firm based in Newington, Conn. Q: Is there a certain format that has to be used ...

Optum Rx, the pharmacy benefits manager operated by healthcare behemoth UnitedHealth, is moving eight popular insulin products to preferred status on its standard formulary for commercially insured ...

Oral phosphodiesterase type 5 (PDE5) inhibitors are the recommended first-line option for the treatment of erectile dysfunction. Currently, three PDE5 inhibitors are approved for use in the United ...

Impact of applying machine learning to the electronic medical record on prediction of cancer-associated thrombosis. Breakdown for provider order entry and pharmacist review with and without drug ...

Start low, go slow” is a strategy used to minimize adverse drug events when prescribing for older people.1 However, low doses are seldom produced by pharmaceutical manufacturers and are often not paid ...